Shariatga muvofiqlik sharhi
HalolTG Therapeutics, Inc. (TGTX) hozirda Akinda shariat skriningi (AAOIFI) bo'yicha Halol deb tasniflanadi.
TG Therapeutics, Inc. haqida
Based in New York City and established in 1993, TG Therapeutics, Inc. is a biopharmaceutical company that has advanced to the commercial stage. Its core mission revolves around the acquisition, advancement, and marketing of novel therapeutic solutions.
TG Therapeutics, Inc. (TGTX) Healthcare sektorida, Biotechnology sohasida faoliyat yuritadi.
Nega halol: aksiya AAOIFI ning uchala tekshiruvidan o'tadi. Nomuvofiq daromad — 0.00% (chegara 5%), foizli qarz — 6.17% (chegara 30%), foizli qimmatli qog'ozlar va aktivlar — 3.45% (chegara 30%).
- Kompaniya faoliyati
- 0.00%Chegara 5%Muvaffaq
- Foizli qarz
- 6.17%Chegara 30%Muvaffaq
- Foizli qimmatli qog‘ozlar va aktivlar
- 3.45%Chegara 30%Muvaffaq
- Dividendlarni poklash
- 0.00%Xayriyaga beriladigan dividend ulushiPoklash kalkulyatori
Oxirgi yangilanish: 3-noy, 2026 · Skrining ma'lumot uchun; bu fatvo emas. Shaxsiy maslahat uchun malakali olim bilan maslahatlashing.
Kontentni ko'rish uchun tizimga kiring
Kontentni ko'rish uchun tizimga kiring
Kontentni ko'rish uchun tizimga kiring
Kompaniya profili
Kontentni ko'rish uchun tizimga kiring
Tez-tez beriladigan savollar
TG Therapeutics, Inc. (TGTX) bo‘yicha qisqa javoblar. Akinda skrining yorlig‘i: Halol.
